Clinical Trial

Study Evaluating the Analgesic Efficacy of Capsaicin 8% Patches in Chronic Coccygodynia.

Study acronym: CAPSACOX
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The primary objective is to demonstrate the analgesic effect at day 60 of 8% capsaicin patch (Qutenza) for the treatment of patients with coccygodyinia.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2023-09-04; most recent amendment 2026-02-20.
Status change: Not Yet Recruiting → Recruiting 2023-11-10
Trial Details
NCT Number NCT06023706
Lead Sponsor Nantes University Hospital
Conditions Coccyx Disorder, Neuropathic Pain, Coccygodynia
Enrollment 188 participants
Start Date 2023-11-08
Primary Completion 2027-01-08 (estimated)
Study Completion 2027-06-08 (estimated)
Updated on ClinicalTrials.gov 2026-02-24